AKT1 and Alzheimer disease: Several recent studies employing this methodology have uncovered that traditional memory-enhancing formulas regulate PI3K/AKT, Nrf2, MAPK, and NF-κB pathways key nodes in the AD signaling network (Fão et al., 2019).